Back to search

Article

Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: A nationwide retrospective cohort study

2025-11-20

Abstract excerpt

<title>Abstract</title> <p>Purpose Stroke is a leading cause of death and disability worldwide. Clopidogrel, an antiplatelet agent that is commonly used for the secondary prevention of ischemic stroke, yet the data on the efficacy and safety of generic versus brand-name clopidogrel remain limited. The aim of this retrospective cohort study was to compare the efficacy and safety of generic clopidogrel with brand-n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a866152b-1c66-5691-a82d-02417f3c5214
DOI
10.21203/rs.3.rs-7667267/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: A nationwide retrospective cohort studyDOI 10.21203/rs.3.rs-7667267/v1
Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial.Semantic proximity
Short-term efficacy and safety of personalized antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: A randomized clinical trial.Semantic proximity
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewSemantic proximity
Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity
Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.Semantic proximity
A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysisSemantic proximity
Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity
Efficacy and Mechanism of Panax Notoginseng in the Secondary Prevention for Stroke Patients with "Antiplatelet Drug Resistance"Semantic proximity
The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis.Semantic proximity
Report: Impact of drug combination of clopidogrel and pantoprazole In the prognosis of patients with transient ischemic attack.Semantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Cost-effectiveness analysis of CYP2C19 genotype-guided antiplatelet therapy for patients with acute minor ischemic stroke and high-risk transient ischemic attack in China.Semantic proximity
Select a neighboring publication to make it the new centre.